- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05612776
HIIT vs HRV-based Training for Rehabilitation After Stroke
November 4, 2022 updated by: María Carrasco Poyatos, Universidad de Almeria
High Intensity Interval Training (HIIT) vs Heart Rate Variability (HRV) Training for Cardiac and Functional Rehabilitation After Stroke
Consequences of stroke are manyfold but all of them are important factors on the long-term outcomes of rehabilitation, becoming an important health problem with requires health strategies with advanced age.
High intensity interval training (HIIT) is an efficient training protocol used in cardiac rehabilitation programs, but owing to the inter-individual variability in physiological responses to training associated to cardiovascular diseases, the exercise dose received by each patient should be closely controlled and individualized to ensure the safety and efficiency of the exercise program.
The heart rate variability (HRV) is actually being used for this purpose, as it is closely linked to de parasympathetic nervous system activation.
In this way, higher scores in HRV are associated with a good cardiovascular adaptation.
The objective of this protocol is to determine the effect of HIIT compared with HRV-guided training on cardiorespiratory fitness, heart rate variability, functional parameters, body composition, quality of life, inflammatory markers, cognitive function, and feasibility, safety and adherence in patients after stroke undertaking an 8-week cardiac rehabilitation program.
This will be a cluster-randomized controlled protocol in which patients after stroke will be assigned to an HRV-based training group (HRV-G) or a HIIT-based training group (HIIT-G).
HIIT-G will train according to a predefined training program.
HRV-G training will depend on the patients' daily HRV.
The peak oxygen uptake (VO2peak), endothelial and work parameters, the heart rate variability, the functional parameters, the relative weight and body fat distribution, the quality of life, the inflammatory markers, the cognitive function, and the exercise adherence, feasibility and safety will be considered as the outcomes.
It is expected that this HRV-guided training protocol will improve functional performance in the patients after stroke, being more safe, feasible and generating more adherence than HIIT, providing a better strategy to optimize the cardiac rehabilitation interventions.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: María Carrasco, PhD
- Phone Number: 84773 +34950214773
- Email: carrasco@ual.es
Study Locations
-
-
-
Almería, Spain, 04120
- Recruiting
- CITE III
-
Contact:
- María Carrasco, PhD
- Phone Number: 84773 950214773
- Email: carrasco@ual.es
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- left ejection fraction higher than 30% after stroke
- aged between 18 and 80 years old
Exclusion Criteria:
- presence of absolute or relative contraindications for accomplishing the treadmill test, indicated by the Spanish Society of Cardiology
- being treated for other diseases, or regularly taking a drug(s) that has a direct or indirect effect on the nervous system (e.g., anxiolytics, antidepressants or neuroleptics)
- absence of medication to control the cardiovascular disease or its modification during the intervention
- people who are participating or have participated in the previous three months in other similar exercise programs
- not performing at least 80% of the workouts during the intervention
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: HIIT-based training
The HIIT group will train according to a predefined high intensity training program
|
HIIT training will consist of performing high intensity intervals along with passive rests.
The intensity of the exercise will be progressively increased and the rest time will be decreased.
All participants will perform the same training according to the maximum heart rate reached in the Bruce test.
|
|
Experimental: HRV-based training
The training prescribed to the HRV group will depend on the subjects' diary HRV
|
The intervention group will perform HRV-based training, measuring HRV every day before training in order to obtain HRV normality ranges for each participant.
If the HRV value is within the normal range, the participant will perform a high intensity training but if the HRV value is below the normal range, the participant will perform a continuous training at low intensity as active rest.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak oxygen uptake (VO2peak) changes
Time Frame: baseline and week 8
|
According to the Spanish Society of Cardiology, the modified Bruce procotol will be used as a treadmill test, as it is indicated for people considered to be at high risk and the elderly.
|
baseline and week 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart rate variability
Time Frame: every day before starting the intervention
|
HRV is proposed to be measured at rest, just before the training session, in a laying position and over a 60 second period.
Smartphone application known as "HRV4Training" will be used.
|
every day before starting the intervention
|
|
Functional performance
Time Frame: Baseline and week 8
|
To measure functional capacity, the Senior Fitness Test battery will be used such as the "Six Minutes Walk Test" Or "Timed Up and Go Tests", as it has been used in previous studies in which a program based on high-intensity training has been implemented with elderly people.
|
Baseline and week 8
|
|
Body mass index (BMI)
Time Frame: Baseline and week 8
|
Height will be measured using a measuring rod (Seca 213), and the body mass index (BMI) will be calculated according to the formula: BMI = kg/m2.
|
Baseline and week 8
|
|
Quality of life MacNew
Time Frame: Baseline and week 8
|
the MacNew QLMI post-myocardial infarction quality of life questionnaire will be administered.
Consists of a 27-question questionnaire answered on a scale of 1 to 7, where 1 means "always" and 7 means "never".
|
Baseline and week 8
|
|
Number of participants with abnormal laboratory test results
Time Frame: baseline and week 8
|
The blood analysis will include the lipid profile, the detection and quantification of plasma insuline and its' resistance.
|
baseline and week 8
|
|
Waist-to-hip ratio
Time Frame: Baseline and week 8
|
As body fat distribution can vary substantially, and having into account that abdominal adiposity has been associated with coronary heart disease, Waist-to-hip ratio will be measured according to International Society for the Advancement of Kinanthropometry Standards.
|
Baseline and week 8
|
|
Waist-to-height ratio
Time Frame: Baseline and week 8
|
In the same way, waist-to-height ratio will be also measured as a recent systematic reviews with meta-analysis have proposed it as a better predictor of cardiovascular risk factors.
|
Baseline and week 8
|
|
Cognitive function, spatial memory recognition test
Time Frame: baseline and week 8
|
the spatial memory recognition test (ASMRT), a simple virtual reality based task for specific population like older adults and with proved sensitivity to gender differences
|
baseline and week 8
|
|
Cognitive function, virtual version of the Walking Corsi test
Time Frame: baseline and week 8
|
the virtual version of the Walking Corsi test (VR_WalCT) will be used to measure topographical memory, as proved its' equivalency regarding the real environment one
|
baseline and week 8
|
|
Cognitive function, Trail Making Test
Time Frame: baseline and week 8
|
the Trail Making Test (TMT) will be used to detect neurological disease and neuropsychological impairment through the cognitive domains of processing speed, sequencing, mental flexibility and visual-motor skills.
|
baseline and week 8
|
|
Exercise Adherence
Time Frame: up to 8 weeks
|
Adherence will be assessed by the number of sessions completed by the participants.
At least, the 80% of the sessions should be achieved to consider a successful adherence.
|
up to 8 weeks
|
|
Feasibility study
Time Frame: up to 8 weeks
|
Feasibility study will be considered as the compliance to the exercise protocol, and will be registered as the percentage of participants that finished every training session.
|
up to 8 weeks
|
|
Safety study
Time Frame: up to 8 weeks
|
Safety study will be measured as the numbers of adverse events occurred during the training sessions.
They will be registered as mild, moderate and severe.
Moreover, their relation to the exercise session will also be taken into account.
|
up to 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
December 1, 2022
Primary Completion (Anticipated)
August 1, 2023
Study Completion (Anticipated)
December 1, 2023
Study Registration Dates
First Submitted
July 19, 2022
First Submitted That Met QC Criteria
November 4, 2022
First Posted (Actual)
November 10, 2022
Study Record Updates
Last Update Posted (Actual)
November 10, 2022
Last Update Submitted That Met QC Criteria
November 4, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Coronary Disease
- Heart Diseases
- Stroke
- Coronary Artery Disease
- Myocardial Ischemia
- Ischemic Stroke
- Ischemia
Other Study ID Numbers
- AHIITATE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on HIIT
-
University of Erlangen-Nürnberg Medical SchoolUnknownMetabolic Syndrome | Overweight and ObesityGermany
-
Beijing Sport UniversityCompleted
-
Beijing Sport UniversityCompletedNormal Weight ObesityChina
-
Karabuk UniversityCompletedExercise Performance | Physical Fitness | Neuromuscular FunctionTurkey (Türkiye)
-
University of SevilleRecruitingInsulin Growth Factor I Deficiency | IGF1 Deficiency | Executive Function DisorderSpain
-
USDA Grand Forks Human Nutrition Research CenterCompletedObesity | OverweightUnited States
-
Karolinska InstitutetWithdrawn
-
University of Erlangen-Nürnberg Medical SchoolUnknownHealth Promotion | Primary PreventionGermany
-
Riphah International UniversityRecruiting
-
Hull University Teaching Hospitals NHS TrustTerminated